section-8b95cd0
PIONEERING AS A PHARMACEUTICAL SUPPLIER OF MEDICINAL CANNABIS
01. Providing for Today
About Us
STATE OF THE ART CULTIVATION AND ADVANCED GENETIC STRAINS
02. Innovations
About Us
.oktan .tp-bullet{background:#fff; opacity:0.5; width:50px; height:2px}.oktan .tp-bullet:hover,.oktan .tp-bullet.selected{opacity:1}.oktan .tp-bullet-counter{color:#fff; display:none; font-family:”Work Sans”,sans-serif; font-size:16px; font-weight:600; left:50%; position:absolute; top:-25px; -webkit-transform:translateX(-50%); transform:translateX(-50%)}.oktan .tp-bullet.selected .tp-bullet-counter{display:inline-block}@media(max-width:590px){.oktan{transform:matrix(1,0,0,1,-80,-20) !important}}
section-317833c
section-2af522d
CINV Corp
At CINV Corp we plan to become world leaders in the production of medicinal cannabis. We intend to supply extracts and product such as GMP-Flower, GMP-Oil to the pharmaceutical industry as an API (Active Pharmaceutical Ingredient) to meet the increasing global demand for a high specification medicinal cannabis product and transform lives.
We are based in the heart of London with rapidly expanding production operations in Africa.
section-de2319f
Our Mission
We are passionate about the scientific evidence that proves the potential of medicinal cannabis and we will provide a highly effective API to the pharmaceutical industry for global distribution.
With agreements already in place to supply in the future a GACP & EU-GMP certified medicinal cannabis product via our cultivation facility in Africa that will include R&D facilities and an active breeding programme to create proprietary genetic variants of medicinal cannabis.
section-7036458
Our Background
We are the first company to hold a medicinal cannabis licence in Zimbabwe.
With our connections and local trust, we feel we have a growing social responsibility to be a part of rebuilding the Zimbabwean economy, you can read more about Our Job Creation and Community Outreach Programs here.
section-1d04f68
Contact Us
CINV Corp focuses on export to global regions with a heavy destination focus on Europe which is predicted to be the world’s biggest over the next 10 years. According to Prohibition Partners – Europe’s cannabis market is estimated to be worth up to €123 billion by 2028. CINV Corp intends, through first-mover advantage to become the biggest producer of CBD oil in Southern Africa.
To learn more about how to invest, please visit our investment fund-vehicle, JPD Capital.
section-02b43d9
section-37151bf
FAQ & Information
Get in touch with us here and a member of our team will get back to you within 24 hours.
For comment, interviews and other press & media related enquiries please contact our PR team at [email protected]
Do you require medicinal cannabis for yourself or a child? You can learn more about how we can support you via the CINV Corp Foundation here
section-51d8087
Our Team
Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam.
JP Doran
CEO & Founder
Timothy Ambrose
Co-Founder & COO
Tommy Doran
MD (Zimbabwe)
Soheil Ghaffari
Head of Cultivation
Tajana N. Emmett
Accountant
Justine E. Inger
Manager
section-0925f11
All For Good. Good For All.
section-1b0e0de
Global Distribution Forecast
15,470
Kg
EU-GMP cannabis flower
1,591
Kg
EU-GMP Oil
6
Strains
In Cultivation
section-eb021e1
Latest News
Our Blog
The Current Outlook on Cannabis IPO, with Robert Jappie
Robert Jappie is a lawyer and partner at Ince Gordon Dadds LLP, specialising in Life Sciences and Cannabis Regulation for the UK and Europe. CINV Corp is a cannabis company that will soon list on the stock market, we ask his expert opinion on the pros and cons of a traditional .
Research and Development: Why is this so important for a cannabis company?
Research and Development plays an important role in the success .
Why Pre-IPO Investments Make Sense: Cannabis Stock Prices Soar Post Flotation
The “Green Rush” is fast becoming an investor’s favourite when .